GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » Cyclically Adjusted Revenue per Share

Utah Medical Products (Utah Medical Products) Cyclically Adjusted Revenue per Share : $14.13 (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Utah Medical Products Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Utah Medical Products's adjusted revenue per share for the three months ended in Dec. 2023 was $3.394. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $14.13 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Utah Medical Products's average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Utah Medical Products was 8.00% per year. The lowest was 4.20% per year. And the median was 5.80% per year.

As of today (2024-05-01), Utah Medical Products's current stock price is $68.61. Utah Medical Products's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $14.13. Utah Medical Products's Cyclically Adjusted PS Ratio of today is 4.86.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Utah Medical Products was 10.89. The lowest was 4.67. And the median was 6.81.


Utah Medical Products Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Utah Medical Products's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products Cyclically Adjusted Revenue per Share Chart

Utah Medical Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.45 11.93 12.86 13.69 14.13

Utah Medical Products Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.91 14.07 14.19 14.13 -

Competitive Comparison of Utah Medical Products's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Utah Medical Products's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Utah Medical Products's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Utah Medical Products's Cyclically Adjusted PS Ratio falls into.



Utah Medical Products Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Utah Medical Products's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.394/129.4194*129.4194
=3.394

Current CPI (Dec. 2023) = 129.4194.

Utah Medical Products Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 2.595 99.695 3.369
201406 2.779 100.560 3.577
201409 2.847 100.428 3.669
201412 2.714 99.070 3.545
201503 2.710 99.621 3.521
201506 2.756 100.684 3.543
201509 2.639 100.392 3.402
201512 2.540 99.792 3.294
201603 2.732 100.470 3.519
201606 2.778 101.688 3.536
201609 2.556 101.861 3.248
201612 2.367 101.863 3.007
201703 2.752 102.862 3.463
201706 2.902 103.349 3.634
201709 2.709 104.136 3.367
201712 2.723 104.011 3.388
201803 2.905 105.290 3.571
201806 2.921 106.317 3.556
201809 2.768 106.507 3.363
201812 2.611 105.998 3.188
201903 2.871 107.251 3.464
201906 3.172 108.070 3.799
201909 3.343 108.329 3.994
201912 3.162 108.420 3.774
202003 2.927 108.902 3.478
202006 2.401 108.767 2.857
202009 2.869 109.815 3.381
202012 3.287 109.897 3.871
202103 3.000 111.754 3.474
202106 3.448 114.631 3.893
202109 3.437 115.734 3.843
202112 3.517 117.630 3.870
202203 3.362 121.301 3.587
202206 3.679 125.017 3.809
202209 3.565 125.227 3.684
202212 3.745 125.222 3.871
202303 3.443 127.348 3.499
202306 3.536 128.729 3.555
202309 3.436 129.860 3.424
202312 3.394 129.419 3.394

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Utah Medical Products  (NAS:UTMD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Utah Medical Products's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=68.61/14.13
=4.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Utah Medical Products was 10.89. The lowest was 4.67. And the median was 6.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Utah Medical Products Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Utah Medical Products (Utah Medical Products) Business Description

Traded in Other Exchanges
Address
7043 South 300 West, Midvale, UT, USA, 84047
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
Executives
Paul O Richins director, officer: VP, Treasurer, Asst. Secretary 7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne director
Ernst G Hoyer director
Kevin L Cornwell director, officer: Chairman, CEO, Secretary
Brian Koopman officer: Principal Financial Officer 108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson director 7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire officer: Chief Financial Officer 5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett director

Utah Medical Products (Utah Medical Products) Headlines

From GuruFocus

Utah Medical Products, Inc. Announces Quarterly Dividend

By ACCESSWIRE ACCESSWIRE 08-02-2022

Utah Medical Products, Inc. Announces Quarterly Dividend

By ACCESSWIRE ACCESSWIRE 02-09-2021

Utah Medical Products, Inc. Announces Quarterly Dividend

By ACCESSWIRE ACCESSWIRE 05-11-2021

Utah Medical Products, Inc. Announces Quarterly Dividend

By ACCESSWIRE ACCESSWIRE 02-07-2023

Utah Medical Products, Inc. Announces Special Dividend

By ACCESSWIRE ACCESSWIRE 11-02-2021